IndraLab

Statements


USP9X activates JAK2. 2 / 2
| 2

reach
"We further found that activated JAK2 may be naturally suppressed in 25% of CRLF2 pos DS-ALLs by loss-of-function aberrations in USP9X, a deubiquitinase previously shown to stabilize the activated phosphorylated JAK2."

reach
"USP9X positively regulated the JAK2 and STAT3 pathway to promote the malignant progression of liver cancer cells."